The differential H3K27ac enrichment of RTK I and MES SEs, the expression of SE-defined subtype identity genes and MR activity of the RTK I and MES MRs identified in the CRC analysis also correlated with this methylation gradient (Fig. 7f–h). The gene discussed is NR3C2; the disease is colorectal carcinoma.